This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
11-13 November 2025
Congress Center BaselBasel, Switzerland

Dr. Sonja Merkas, PhD
Founder, Creator and Doer at Livinovea
Speaker

Profile

Sonja Merkas, PhD, is the founder of Livinovea, a hands-on, service-providing consultancy supporting life science organizations across technical, operational, and business aspects. With over 25 years in the industry, she has worked with small molecules, peptides, and oligonucleotides. Her oligonucleotide journey began in 2003 during her PhD and postdoc and continued with a decade at Novartis leading oligo portfolios and R&D projects. A Lean Six Sigma Black Belt, Sonja combines operational excellence with a strategic, visionary mindset. Livinovea helps organizations unlock immediate and lasting value from their assets with an approach combining all three lenses at once.

Agenda Sessions

  • Workshop Co-Moderators’ Welcome and Opening Remarks

    09:00
  • Integrating Manufacturing and Operations in Oligonucleotide CMC

    09:05
  • Chairwoman's Remarks: Case Studies of Innovations and Efficiencies in Oligonucleotide CMC

    08:00
  • Panel Discussion

    11:15